Article info
PDFLetter
Type I interferon signature predicts response to JAK inhibition in haploinsufficiency of A20
- Correspondence to Dr Daniella Muallem Schwartz, NIAID, National Institutes of Health, Bethesda, Maryland, USA; Daniella.Schwartz{at}nih.gov
Citation
Type I interferon signature predicts response to JAK inhibition in haploinsufficiency of A20
Publication history
- Received June 19, 2019
- Revised October 25, 2019
- Accepted November 7, 2019
- First published November 25, 2019.
Online issue publication
May 12, 2021
Article Versions
- Previous version (12 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.